Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II study of different nab-paclitaxel schedules in metastatic breast cancer
2012-003058-10Phase 2Completed
- Sponsor
- International Breast Cancer Study Group
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of paclitaxel in breast cancer (3 arms), sponsored by International Breast Cancer Study Group. Primary endpoint: Progression-free survival. Started Jan 2013; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-003058-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003058-10.